RT @RichardPAConway: Wu et al Phase 3 RCT of Telitacicept (targets BlyS and APRIL) in SLE. Primary endpoint met at week
Tweet Content
Wu et al Phase 3 RCT of Telitacicept (targets BlyS and APRIL) in SLE. Primary endpoint met at week 52! SRI(4) 67% vs 33% or 83% vs 38% (P<0.001 for both) depending on how you want to slice it. @RheumNow #ACR22 Abstr#L07 https://t.co/nnKr4AU8Jk https://t.co/9BVF6OljFQ
Links
Telitacicept, a Human Recombinant Fusion Protein Targeting B Lymphocyte Stimula…
https://acrabstracts.org/abstract/telitacicept-a-human-recombinant-fusion-prote…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off